cancer cells. Also our findings suggest that through the inhibition of HSP90 activity, antitumor effect of PI3K/mTOR inhibitor and platinum combination therapy can be synergistically potentiated.
INTRODUCTION AND OBJECTIVES: The molecular mechanisms of muscle invasion and distant metastasis in bladder cancer (BC) are not well understood. MicroRNA (miRNA) expression signature of various human cancers have reported that miR-26a-5p/-26b-5p were frequently downregulated in cancer tissues, suggesting these miRNAs act as tumor-suppressors. However, their functions in BC remains unknown. The aim of this study was to investigate the functional role of /-26b-5p and to identify molecular targets that contribute to metastasis in BC.
METHODS: Expression of miR-26a-5p/-26b-5p and their target genes were evaluated in 69 BC clinical BC specimens and 23 normal bladder epithelia (NBE) by real-time PCR. We performed gain-of-function studies (cell proliferation, migration and invasion) by using miR-26a/b transfectants in BC cell lines (T24 and BOY). Putative target genes were listed by in-silico study using the gene expression omnibus (GEO) and TargetScan. We performed loss-of-function studies by using si-RNA transfectants to evaluate the functional role of the target gene. Luciferase reporter analyses were employed to validate direct binding between the target gene and miR-26a/b in BC cells. Overall survival (OS) of the BC patients was evaluated by the Kaplan-Meier analysis.
RESULTS: The expression levels of miR-26a-5p/-26b-5p in clinical BCs were significantly downregulated compared to that in NBE (p < 0.0001 and p ¼ 0.0006, respectively). miR-26a-5p/-26b-5p transfectants significantly suppressed cell migration and invasion, suggesting these miRNAs act as tumor-suppressors. Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2) was identified as a direct regulation of miR-26a-5p/-26b-5p by luciferase reporter assay. Kaplan-Meier analysis revealed that the patients with higher PLOD2 expression showed lower overall survival probabilities than those with lower expression (p ¼ 0.0153). Loss-of-function study showed that cell migration and invasion were significantly inhibited in si-PLOD2 transfectans.
CONCLUSIONS: PLOD2 was directly regulated by tumor-suppressive miR-26a-5p/-26b-5p, and might be good prognostic markers for survival of BC patients. Recent studies showed that PLOD2 function as a collagen cross-linking enzyme associate with extracellular matrix (ECM) stiffness. Aberrant expression of PLOD2 by regulation of these miRNAs might cause extracellular matrix (ECM) disruption and promoting metastasis. Tomoya Fukawa*, Terumichi Shintani, Kei Daizumoto, Tomoharu Fukumori, Masayuki Takahashi, Hiro-omi Kanayama, Tokushima, Japan INTRODUCTION AND OBJECTIVES: Toll-like receptors (TLRs) play important roles in immune response and have been reported that expression levels of these molecules were related to prognoses of several kinds of cancer. It has been reported that the expression level of TLR4 is reduced in bladder cancer. However, the role of TLR4 in bladder cancer is still unclear. The aim of this study is to clarify the effects of TLR4 expression on prognosis of bladder cancer patients and to elucidate its underlying mechanisms.
METHODS: To evaluate the effects of TLR4 expression on prognosis, we analyzed the clinical outcomes of 95 patients with bladder cancer and also conducted immunohistochemistry for TLR4 in bladder cancer specimens. The cancer-specific survival was determined by Kaplan-Meier method and the statistical significance was examined by Log-rank test. We also performed multivariate analysis to evaluate the relationship between TLR4 expression and clinical outcomes. We checked the effects of TLR4 depletion on cell growth and invasive abilities of bladder cancer cells. To clarify the underlying mechanisms, we also analyzed the gene expression profiles in TLR4depleted cells. These results were validated by quantitative RT-PCR. We also confirmed our finding by using data from public database.
RESULTS: The expression levels of TLR4 were inversely correlated with local invasion and worse prognosis (log-rank test, p¼0.007). Although the effect of TLR4 depletion on cell growth was small, it could dramatically enhance invasion ability of cancer cells. We also observed morphologic changes in these cells. Both gene ontology analysis and gene set enrichment analysis of microarray data revealed that most of upregulated genes in TLR4-depleated cells were related to differentiation of epithelium cells. Among these genes, small proline-rich protein (SPRR) family genes which are related to poor prognosis of squamous cell carcinoma were upregulated in TLR4-depleated cells. By analyzing data from public database, we confirmed that expression levels of SPRRs family genes were inversely correlated with TLR4 expression and positively correlated with poor prognosis of bladder cancer patients. Furthermore, we found that expression of TLR4 diminished in the areas with squamous differentiation in bladder cancer.
CONCLUSIONS: Our finding suggested that TLR4 is related to bladder cancer aggressiveness through regulation of squamous differentiation. Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1319
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